Partnerships & Mergers

Once the transaction successfully closes, the combined company plans to operate under the PrimeGen US name or through a successor entity.

The collaboration enables Sidra Medicine to connect Builders VC’s expertise and extensive network with their clinical teams, patient populations, and technological platforms.

The company plans to utilize two key facilities for this production: its Oxford, United Kingdom site and its Durham, North Carolina location.

The partnership builds on a Memorandum of Collaboration signed last year under the Global Oncology Initiative, which set the foundation for comprehensive cancer management improvements at the regional referral facility.

The acquisition encompasses MDCO’s complete portfolio of ophthalmic devices, including intraocular lenses (IOL), implantable contact lenses (Phakic Lens), and various refractive device platforms.

HC21 UK will showcase its capabilities at the ABHI UK Pavilion located in Hall 2, where members of its Irish management team will join forces to demonstrate the group’s comprehensive approach to market expansion.

In 2021 alone, bacterial AMR directly caused 1.14 million deaths worldwide. Without immediate intervention, experts forecast that bacterial AMR will claim 39 million lives over the next 25 years

Amplifai Health’s acceptance into this programme validates the company’s approach to implementing AI technology in practical healthcare settings where it can make an immediate difference in patient care.

Through this acquisition, Mirum gains worldwide rights to brelovitug, a monoclonal antibody that has advanced to Phase III clinical development.

Altibbi plans to extend Zain Clinic to Kuwait, Bahrain, and the United Arab Emirates throughout 2026, building on its regional strategy to embed telehealth infrastructure into major digital platforms across the Gulf.